Author

Philip Q. Ding

h-index 6 View on Semantic Scholar

We have 2 of 36 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

The Combination of Atezolizumab and Bevacizumab Versus Lenvatinib as a First-Line Systemic Therapy for Treatment of Hepatocellular Carcinoma: A Real-World Comparison

Introduction: Atezolizumab plus bevacizumab (AB) and lenvatinib (LEN) demonstrate non-inferior survival compared with sorafenib for first-line treatment of unresectable hepatocellular carcinoma (HCC) but have not been directly compared. We retrospectively compared survival outcomes between patients treated with AB and...

K. Jobin, M. Hannouf, Mark Freeman et al. · Current Oncology · 0 citations

Open access 2025

Patient-physician sex concordance and real-world disparities in cancer treatment practices and outcomes in medical oncology

Background: Sex inequities in healthcare may be magni�ed in medical oncology, where patients and physicians often navigate life-limiting illnesses and intensive treatments. We examined the associations among patient-physician sex concordance, treatment practices, and cancer outcomes. Methods: This was a population-base...

Chantelle Carbonell, Philip Q. Ding, Abisola A. Adegbulugbe et al. · Research Square · 0 citations